TCTMD

Medtronic Viva® Cardiac Resynchronization Therapy-Pacemaker Now Available in U.S.

AdaptivCRT® Algorithm Customizes Therapy for Heart Failure Patients and Improves Their Response Rates MINNEAPOLIS - Medtronic, Inc. today announced the U.S. Food and Drug Administration (FDA) approval ...
TCTMD

Medtronic Studies Show Cardiac Resynchronization Therapy Extends Life, Reduces Hospital Readmissions

Data Demonstrate Clinical and Economic Value of Underutilized Treatment for Heart Failure Patients at American Heart Association's Scientific Sessions 2014 MINNEAPOLIS and CHICAGO - Medtronic, Inc.
The American Journal of Managed Care

Patients With Chemotherapy-Induced Cardiomyopathy Show Improvements in LVEF After Cardiac Resynchronization Therapy

With increased recognition of the link between cancer care and heart disease, more studies are evaluating the interconnectedness of cancer survival, chemotherapy, and heart failure (HF) in patients ...
Medscape

Ablate and Pace With Cardiac Resynchronization Therapy for Patients With Reduced Ejection Fraction: Subanalysis of PAVE Study

Presenter: Christopher Fellows, MD, Virginia Mason Medical Center (Seattle, Washington) on behalf of the PAVE Study Group: LV based Cardiac Stimulation Post AV Nodal Ablation E valuation The ...
Healio

Cardiac resynchronization therapy displays long-term benefits vs. ICD in HFrEF

Please provide your email address to receive an email when new articles are posted on . Long-term CRT-D use was tied to improved survival and time to adverse events vs. ICD therapy in patients with ...
Medscape

ESC Updates Guidance on Cardiac Pacing, Resynchronization Therapy

The European Society of Cardiology (ESC) has released updated guidelines for cardiac pacing and cardiac resynchronization therapy (CRT), which emphasize patient-centered care and shared ...
Business Wire

FDA Grants EBR Systems Breakthrough Device Designation Status for the WiSE Cardiac Resynchronization Therapy (CRT) System

SUNNYVALE, Calif.--(BUSINESS WIRE)--EBR Systems, Inc., developer of the world’s only wireless cardiac pacing system for heart failure, today announced that the U.S. Food and Drug Administration (FDA) ...
EurekAlert!

Cardiac resynchronization therapy benefits cancer survivors with heart failure

A pacemaker-like device restored heart function in a group of cancer survivors -- mostly women with breast cancer -- who had suffered from heart failure as a result of chemotherapy treatment, a study ...
Medical Xpress

Therapeutics: News and Research on Cardiac Resynchronization Therapy

The European Society of Cardiology (ESC) has released a groundbreaking consensus statement on conduction system pacing (CSP), marking a significant milestone in the evolution of pacing therapy. The ...
Nature

Does cardiac resynchronization therapy reduce the long-term mortality risk in patients with heart failure?

Cardiac resynchronization therapy (CRT), with or without a defibrillator, has been shown to improve symptoms, quality of life, and prognosis in patients with moderate-to-severe heart failure (HF) ...
Nature

Cardiac resynchronization therapy or atrio-biventricular pacing—what should it be called?

Reduced cardiac efficiency caused by suboptimal synchronization of the heart's normal contraction might contribute to the development of or exacerbate heart failure. Conceptually and in practice ...